GLP-1s are changing US healthcare, should everyone be on them?

"Life-Changing Medications for Obesity: How GLP-1 Drugs Are Revolutionizing US Healthcare A new wave of medications, originally designed to combat diabetes, is transforming the way Americans fight obesity. GLP-1 (Glucagon-Like Peptide-1) drugs, which have been on the market for over a decade, have seen a surge in popularity as a treatment for obesity, with many experts hailing them as a game-changer in the fight against the growing health epidemic. By mimicking the body's natural appetite-regulating hormones, these medications have been shown to promote significant weight loss and improve overall health outcomes for millions of Americans. As their use continues to expand, healthcare professionals and policymakers are taking notice, raising questions about the long-term implications and potential cost savings of these innovative treatments."

GLP-1 drugs, originally developed to treat diabetes and now widely used for obesity, are reshaping healthcare in the US.